CTS appoints Amy M. Dodrill to board of directors, effective Feb 8

CTS CORP

Board expanded from six to seven members; Dodrill fills the vacancy.
Dodrill most recently President of Baxter's $2B Global Surgical Solutions and Patient Support Systems segment.
She also serves on Procept BioRobotics (PRCT) board, on audit and compensation committees.
Dodrill appointed to nominating, governance and sustainability and technology and transactions committees.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Amy M. Dodrill

Director

CTS · CTS CORP

Effective: 2024-02-08
Filed: February 8, 2024, 6:59 PM ET

Effective February 8, 2024, the board of directors (the “Board”) of CTS Corporation (the “Company”) increased the size of its board from six to seven members, and elected Amy M. Dodrill to fill the resulting vacancy.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Amy M. Dodrill was elected as Director at CTS CORP.

Action: elected
Role: Director

Exact text from the filing

Effective February 8, 2024, the board of directors (the “Board”) of CTS Corporation (the “Company”) increased the size of its board from six to seven members, and elected Amy M. Dodrill to fill the resulting vacancy.

View on SEC.gov

CTS CORP filing history →

Source: SEC EDGAR

accession 0000950170-24-012847

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.